Sri Karthikeya Bio & Pharma Projects Private Limited

Sri Karthikeya Bio & Pharma Projects Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U33111TG2015PTC098912 Incorporated 14 May 2015 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹10.22 Cr
▲ 222% YoY
Net profit · FY 2025
₹32.32 Lakh
Net margin 3.2%
EBITDA · FY 2025
₹72.13 Lakh
EBITDA margin 7.1%
Authorised capital
₹1.2 Cr
Registered with MCA
Paid-up capital
₹55 Lakh
Issued & subscribed
Open charges
₹14.53 Cr
Satisfied ₹80 Lakh
Company age
11 yrs
Est. 2015
Employees · EPFO
23
Provident fund records

About Sri Karthikeya Bio & Pharma Projects Private Limited

Data last updated:

Sri Karthikeya Bio & Pharma Projects Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 May 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33111TG2015PTC098912. Its GSTIN is 36AAVCS8180P1Z4 (Telangana).

The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹55 Lakh. It is led by directors Shivaram Prasad Golla and Veerla Saithirumal Rao.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 93 Ground Floor Vijayanagar Colony Near Patelkunta Park, Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹10.22 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32.32 Lakh (net margin 3.2%) and EBITDA of ₹72.13 Lakh (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 20% over five years.

The company has about 23 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹14.53 Cr and satisfied charges of ₹80 Lakh on record.

Sri Karthikeya Bio & Pharma Projects Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0012295). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U33111TG2015PTC098912
Registration Number 098912
Incorporation Date 14 May 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0012295

Recognitions & Rankings of Sri Karthikeya Bio & Pharma Projects

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-02-0012295

Contact details

Sri Karthikeya Bio & Pharma Projects Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    2 – 22 – 93 Ground Floor Vijayanagar Colony Near Patelkunta Park Montessori School, Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.

Comprehensive company report
Sri Karthikeya Bio & Pharma Projects Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sri Karthikeya Bio & Pharma Projects is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.

Financials of Sri Karthikeya Bio & Pharma Projects Private Limited

FY 2025 filings available

Sri Karthikeya Bio & Pharma Projects Private Limited reported revenue of ₹10.22 Cr (up 222% YoY) for FY 2025.

Revenue · FY 2025
₹10.22 Cr ▲ 222%
Net profit · FY 2025
₹32.32 Lakh margin 3.2%
EBITDA · FY 2025
₹72.13 Lakh margin 7.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 222%
3 years · compounded
▲ 40%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 290%
3 years · compounded
▲ 54%
5 years · compounded
▲ 9%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 222% growth in the latest year. EBITDA rose 290% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹72.13 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹32.32 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.1%
Net Profit Margin3.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.

Board of directors of Sri Karthikeya Bio & Pharma Projects Private Limited

Sri Karthikeya Bio & Pharma Projects has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shivaram Prasad GollaDirector06 Aug 201511 Years 2 MonthsCurrent
Veerla Saithirumal RaoDirector13 Sep 20179 Years 1 MonthsCurrent

Peer comparison

Sri Karthikeya Bio & Pharma Projects Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medwin Pharmaceuticals Private Limited₹10.29 Cr (FY 2025)19.0%Aligarh, Uttar Pradesh, India
Elinor Healthcare Private Limited₹10.28 Cr (FY 2024)831.0%Hyderabad, Telangana, India
Voizmed Pharma Private Limited₹10.24 Cr (FY 2024)23.0%Panchkula, Haryana, India
Bestel Laboratories Private Limited₹10.23 Cr (FY 2025)31.0%Anand, Gujarat, India
Sri Karthikeya Bio & Pharma Projects Private Limitedthis company₹10.22 Cr (FY 2025)₹32.32 Lakh3.2%222.0%23Hyderabad, Telangana, India
Floreat Medica Private Limited₹10.19 Cr (FY 2025)4.0%Angamaly, Kerala, India

To see the full peer comparison of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.

Auditor

Sri Karthikeya Bio & Pharma Projects Private Limited is audited by RAO RAJU & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RAO RAJU & ASSOCIATESFY 2023011401S

Shareholding

The shareholding of Sri Karthikeya Bio & Pharma Projects Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.

Charges & borrowings

Open charges
₹14.53 Cr
Satisfied charges
₹80 Lakh
Breakdown by lending institutions
Hdfc Bank Limited₹14.53 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Oct 2020100386610Hdfc Bank Limited₹21.12 LakhOpen
13 Feb 2019100244913Hdfc Bank Limited₹14.31 CrOpen
20 Sep 2016100051818Others₹80 LakhSatisfied

To see the full charge records of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sri Karthikeya Bio & Pharma Projects Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sri Karthikeya Bio & Pharma Projects Private Limited has a workforce of 23 employees on its EPFO records as of Oct 31, 2024, across 1 active EPFO establishment.

Employee count
23
Active EPFO establishments
1
Employee growth
-4.17%

GST

Sri Karthikeya Bio & Pharma Projects has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAVCS8180P1Z4TelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Sri Karthikeya Bio & Pharma Projects Private Limited, buy the company report.

Recent activity

Sri Karthikeya Bio & Pharma Projects Private Limited has 10 board changes on record since 2015: 6 appointments and 4 cessations. The latest: Ahalya Pandillapalli ceased to be Director on 22 May 2023.

AGM
Sri Karthikeya Bio & Pharma Projects Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sri Karthikeya Bio & Pharma Projects Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Ahalya Pandillapalli ceased to be Director.
Ceased
Rangineni Karthik ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 14.31 Cr registered on 13 Feb 2019 with Charge ID 100244913 was modified on 16 Mar 2022.
Ceased
Rachakonda Sai Ramakrishna Rao ceased to be Additional Director.
Appointed
Rachakonda Sai Ramakrishna Rao was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100386610 was registered on 09 Oct 2020.
Charges
A charge registered on 20 Sep 2016 via Charge ID 100051818 with Others was fully satisfied on 06 Mar 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.31 Cr with Charge ID 100244913 was registered on 13 Feb 2019.
Ceased
Rangineni Padmaja ceased to be Director.
Appointed
Veerla Saithirumal Rao was appointed as Director.

6 earlier events are in the company report.

Frequently asked questions

Sri Karthikeya Bio & Pharma Projects is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 May 2015 (11+ years old) and is registered under CIN U33111TG2015PTC098912.

Sri Karthikeya Bio & Pharma Projects has 2 current directors:

The latest financial statements of Sri Karthikeya Bio & Pharma Projects on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Sri Karthikeya Bio & Pharma Projects is 36AAVCS8180P1Z4, registered in Telangana.

The CIN (Corporate Identification Number) of Sri Karthikeya Bio & Pharma Projects is U33111TG2015PTC098912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sri Karthikeya Bio & Pharma Projects was incorporated on 14 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Sri Karthikeya Bio & Pharma Projects by revenue are Medwin Pharmaceuticals Private Limited, Elinor Healthcare Private Limited, Voizmed Pharma Private Limited, Bestel Laboratories Private Limited, Floreat Medica Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Ahalya Pandillapalli ceased to be Director on 22 May 2023. Rangineni Karthik ceased to be Director on 22 May 2023. Rachakonda Sai Ramakrishna Rao ceased to be Additional Director on 18 Oct 2021. Sri Karthikeya Bio & Pharma Projects has 10 board changes on record in total.

Yes, Sri Karthikeya Bio & Pharma Projects is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0012295).

The registered office of Sri Karthikeya Bio & Pharma Projects is at 2 – 22 – 93 Ground Floor Vijayanagar Colony Near Patelkunta Park Montessori School, Kukatpally, Hyderabad, Telangana, India – 500072.

Sri Karthikeya Bio & Pharma Projects operates in the pharma industry, in the drug formulation and development segment.